The trusted source for
healthcare information and
Women who wish to participate in the mifepristone trial at the University of Texas M.D. Anderson Cancer Center must fit the following criteria:
Patients will undergo a physical exam and laboratory work once a month. At the end of eight weeks, a computed tomography scan will be done to see if mifepristone is helping shrink endometrial tumors. Participants with stable disease or improvement may take the drug for as long as it benefits them. Patients who experience significant side effects may have treatment interrupted until the side effects resolve.
Study participants are responsible for the cost of the trial drug. Women are advised to check with their health insurance carrier for possible coverage.
For more information or to register for the trials, contact Jacalyn Gano, RN, telephone (713) 794-1422, or e-mail email@example.com. Further information on the trial is available at the following web site: www.mdanderson.org/mifepristone.